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ABSTRACT 
Introduction 
Oxytocin is widely used as a uterotonic agent for preventing post partum haemorrhage. In 
the setting of caesarean section (CS) the dose and mode of administration of oxytocin 
differs according to different guidelines. This may be a source of uncertainty among the 
different prescribers of the drug. Most of the guidelines available, recommend a slow 
intravenous bolus of 5 international units (iu). Alternatively, an infusion of 20 iu over two 
hours is endorsed by the World Health Organisation (WHO). However, there have been 
many recent studies looking at the prophylactic use of oxytocin at caesarean section to 
prevent haemorrhage associated with the surgery. Although these studies have 
unequivocally shown that doses of oxytocin needed for prophylaxis against uterine atony 
at caesarean section are lower than those routinely used, many clinicians still use 
generally higher doses. Inappropriate doses of oxytocin have been indentified as 
contributory to some cases of maternal deaths.  
Aim 
The main aim of this study was to clinically audit the current standard of practice with 
regards to the use of oxytocin during caesarean section at a referral hospital in Botswana. 
Methods 
A clinical audit of pregnant women having a caesarean section (CS) and given oxytocin 
at the time of the operation was conducted over a three month period. Data including 
indications for CS; dose regimens of oxytocin; prescribing clinician designation; type of 
anaesthesia used for the CS; and estimated blood loss were collected.  
Results 
A total of 139 patients were included. A wide variety of dosing regimens were observed. 
The most common dose was 20 iu infusion (31.7%). The potentially dangerous regimen 
of 10 iu intravenous bolus of oxytocin was used in 12.9% of CS. Further doses were 
utilized in 57(41%) patients. The top three indications for CS were fetal distress 
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36(24.5%), dystocia 32(21.8%) and a previous CS 25(17%). Estimated blood loss (EBL) 
ranged from 50-2000 ml. General anaesthesia was the most popular type of anaesthesia 
used during the study, accounting for 64% compared to 36% where spinal anaesthesia 
was used. In emergency CS general anaesthesia was used in 81/115 (70.4%) of mothers 
as opposed to 8/24 (33.3%) of elective CS. 
Conclusion 
The use of oxytocin during CS in the local setting does not generally follow 
recommended practice and current literature. This has potentially harmful consequences 
such as increased maternal morbidity and mortality. Education and guidance by evidence 
based national practice guidelines and protocols could help alleviate the problem.  
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INTRODUCTION 
The Millennium Development Goals (MDG) are a United Nations initiative that set 
specific targets for health and development. One of the main targets is the reduction of 
maternal mortality by 75% by the year 2015.
1
The leading causes of maternal death in the 
African setting are haemorrhage (33.9%), sepsis/infections (9.7%) and hypertensive 
disorders (9.1%) according to a World Health Organization (WHO) systemic review of 
2006.
2 
In South Africa, the National Committee for Confidential Enquiries into Maternal 
Deaths (NCCEMD) has identified obstetric haemorrhage as the third most common cause 
of maternal death.
3
 Recent statistical briefs from the Botswana Central Statistics Office 
(CSO) highlight that in 2009, a total of 86 maternal deaths were recorded in Botswana. 
The leading causes were obstetric haemorrhage (15.1%), unspecified HIV disease 
(12.8%) and genital tract and pelvic infections (8.1%).
4
The proportion of obstetric 
haemorrhage occurring in relation to caesarean section is not specified in any of these 
reports. 
Reducing maternal morbidity and mortality is a key Millennium Development Goal 
(MDG) to which Botswana is a signatory. The maternal mortality rate for Botswana is 
relatively high for a middle income country (330 per 100 000) and Botswana is not on a 
trajectory to meet the MDG goal (38 per 100 000).
1
 Over 98% of deliveries in Botswana 
occur in a health facility.
5 
Factors that significantly contribute to maternal morbidity and 
mortality need to be identified and managed in clinical practice. A national Maternal 
Mortality Audit Committee based in the Ministry of Health exists and reviews all cases of 
maternal mortality as they are reported. 
Oxytocin is a commonly used drug in obstetrics to prevent haemorrhage, as part of a 
protocol in induction of labour, augmentation of labour, in the presence of a poorly 
contracting uterus and to maintain good uterine contraction in the third stage of labour. 
Recent research has identified the optimal intravenous dose for post-caesarean section 
oxytocin as 3-5 international units (iu) after delivery of the baby, as a single prophylactic 
dose for all cases to prevent haemorrhage.
6-8
 Dose related complications can and do occur 
and put the life of the pregnant woman at risk. Oxytocin has generally been associated 
with major complications when incorrectly used. These include fetal hypoxia, 
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hyperstimulation of the uterus and uterine rupture.
9
 When given as an intravenous bolus, 
oxytocin causes transient hypotension, reflex tachycardia and an increase in cardiac 
output in a dose related manner.
6,7,8,10
 It has also been noted to cause QT prolongation 
and known to precipitate cardiac arrhythmias.
11
 
 As well as being a preventive measure, the use of oxytocin in the perioperative obstetric 
patient may paradoxically also contribute to maternal morbidity and mortality.
12
 The 
recognition of the potential negative contribution of oxytocin during childbirth has 
resulted in much debate about the appropriate dosing and mode of administration of this 
important drug.  
Caesarean section rates are increasing internationally.
13,14,15,16
 As the number of 
caesarean sections carried out in our hospitals increases, there is also a relative increase 
in the use of uterotonic drugs like oxytocin needed to arrest bleeding occurring during 
this major operation. Guidelines have been developed to assist in safe use of oxytocin in 
order to prevent the morbidity and mortality that may be caused by its adverse effects. 
Although oxytocin is used routinely, there appears to be variation in the approach of 
different users with some use clearly outside the recommended approach.
17,18,25
 
The current standard of practice with regard to the use of oxytocin during caesarean 
section at Princess Marina Hospital  (PMH) has not been assessed and established 
through any formal audit. The aim of this study was to establish the current standard of 
practice in the local setting.  
LITERATURE REVIEW 
Oxytocin has an established role in the management of post partum haemorrhage (PPH). 
The adverse effects of oxytocin have been identified as one of the causes of preventable 
maternal deaths.
12
 
Physiology of Oxytocin 
Oxytocin is a posterior pituitary hormone and was the first among peptide hormones to 
have its structure determined and the first to be chemically synthesized in biologically 
active form.
20
 Oxytocin is produced in the hypothalamus, stored in the posterior pituitary 
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gland and is secreted in a pulsatile manner.
20,43 
Oxytocin receptors have been found in the 
breast, ovary, endometrium and myometrium.
20
 Oxytocin binds to a G-protein on the 
surface of the uterine myocyte. This then leads to the generation of 1,2-diacylglycerol 
(DAG) and inositol 1,4,5-triphosphate (IP3) through the action of phospholipase C on 
phosphatidyl-inositol biphosphate(IP2). DAG stimulates prostaglandin release and IP3 
triggers the sarcoplasmic reticulum to release calcium.
20,24,43
 The increase in intracellular 
calcium concentration caused by its release from the endoplasmic reticulum is not 
adequate for a full activation of the myometrial contractile mechanism, and extracellular 
calcium is necessary for adequate oxytocin action. The oxytocin–G-protein complex 
causes conformational changes in voltage-operated calcium channels and increases 
intracellular entry of calcium and decreases its efflux.
21,43 
The calcium then binds to 
calmodulin and activate myosin light chain kinase thus leading to uterine smooth muscle 
contraction.
20,24
 
The number of oxytocin receptors expressed in the myometrium increases as pregnancy 
advances from 12 weeks gestation.
44 
Following continuous and prolonged exposure to 
oxytocin, there is significant loss in the capacity of the myometrial cells to respond as a 
result of oxytocin receptor desensitisation.
26,43
 
Appropriate dose of oxytocin at caesarean section 
Research has been directed at finding the optimal dose of oxytocin that balances the risk 
of adverse effects with the benefit of preventing haemorrhage during and after caesarean 
section. The minimum effective dose at elective CS was found to be 0.35 iu given as an 
intravenous bolus.
19 
This landmark study proved that the historically high doses of more 
than 5 iu oxytocin were not necessary to maintain uterine contractions post-caesarean 
section as lower doses are equally effective. Other studies have confirmed that doses 
between 0.5 and 3 iu are effective with fewer side effects.
20,21 
More recently, an 
intravenous bolus of 2 iu was found to be superior to a 5 iu intravenous bolus in women 
undergoing elective CS. The lower dose was associated with less haemodynamic 
changes, and less emetic symptoms.
22 
Conversely, the minimum effective dose for non-
elective caesarean section has been determined to be approximately 3 iu.
23
 This 
apparently higher dose requirement for non-elective CS compared to elective CS is 
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consistent with existing evidence of oxytocin receptor desensitization following oxytocin 
exposure during labour.
21,22,26
 In view of the oxytocin receptor desensitation from 
repeated doses, there have been suggestions to consider alternative uterotonics to control 
haemorrhage occurring as a result of uterine atony despite further doses of oxytocin.
24 
The evidence presented by these studies supports the current low dose recommendations 
by the Royal College of Obstetricians and Gynaecologists (RCOG) and the National 
Institute for Health and Clinical Excellence (NICE), both of which recommend 5 iu as an 
intravenous bolus to maintain uterine contraction during caesarean delivery.
27,28
 
However, the studies cited above provide evidence for use of even lower doses of 
oxytocin than is endorsed by current guidelines. 
Although recent research has revealed that lower doses are effective, the licensed 
oxytocin dose for CS is 5 iu by slow intravenous injection, consistent with the current 
RCOG and NICE guidelines.
29
 The literature relating to the appropriate dose of oxytocin 
at caesarean section appears to be limited to Randomised Control Trails mentioned 
above. Systematic reviews on the subject have not been reported even though guidelines 
by professional bodies exist. It is likely that as more research efforts go into investigating 
oxytocin use during CS that higher level evidence pertaining to dosing will emerge from 
future systematic reviews. 
Appropriate infusion rate 
In terms of oxytocin infusion there appears to be no consensus regarding the optimal 
infusion rates needed to prevent haemorrhage at caesarean section.Different infusion 
doses of oxytocin (5-20 iu) during elective CS have been investigated and no benefit was 
found in terms of uterine contraction and amount of blood loss when infusing more than 
5 iu of intravenous oxytocin to term pregnant women undergoing elective CS.
30
  An 
infusion of 5 iu (1 iu/min) was not found to be superior to a 5 iu intravenous bolus in 
terms of estimated blood loss in women undergoing elective CS.
8
 A comparative study 
determined the minimum effective dose at which 90% of elective CS patients were 
judged to have adequate uterine tone to be 0.29 iu/min. This infusion dose is equivalent 
to 15 iu of oxytocin in one litre of intravenous fluid given over one hour. 
31 
The World 
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Health Organisation (WHO) recommends infusing 20 iu oxytocin in one litre of 
crystalloid given 60 drops/min over two hours as prophylaxis against bleeding caused by 
uterine atony during CS.
32
 
Inappropriate use of Oxytocin at caesarean section 
A survey of 240 obstetric anaesthetists in the UK revealed that 87% of the 179 
respondents gave 10 iu oxytocin at caesarean section and 50% of them gave this by rapid 
bolus.
17
 A survey conducted in other countries demonstrated that up to 14% of clinicians 
use a 10 iu bolus oxytocin.
24
 
The Confidential Enquiry into Maternal Deaths in the UK identified the use of 10 iu 
intravenously as a cause of death during the resuscitation of a hypovolaemic patient  
during CS in the period 1997-1999.
12,33  
In South Africa, two maternal deaths have 
recently been linked to the use of high doses of oxytocin.
33 
Statement of problem and objective of this study including relevance to Family 
Medicine  
Family Medicine training in Africa prepares doctors to function within the district health 
system in both primary care and district hospital.
34 Botswana’s health care system is 
based on a primary care model. There are 29 health districts served by 17 primary 
hospitals and 15 district hospitals.
35
 Primary and district hospitals in Botswana are mostly 
staffed by medical officers (non specialists) who provide general medical and surgical 
care. Caesarean section and basic obstetric anaesthesia are among some of the 
competencies required to work in primary and district hospitals. Although recognized as 
a health district, Gaborone does not have a primary nor district hospital and so PMH is 
often utilized as such by default.  
The recently established medical school at the University of Botswana has started post-
graduate training in Family Medicine. Family medicine graduates from this programme 
will soon form part of the workforce in the country’s primary and district hospitals. 
Currently there are few locally trained doctors in the country and according to Dr.K. 
Malefho, the Ministry of Health permanent secretary, more than 60% of all doctors in the 
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country employed by the ministry are not Batswana. (Personal communication, August 
24, 2011)
 
The few Batswana non specialist doctors who work in the primary and district 
hospitals, began their medical careers at one of the major referral hospitals before being 
transferred to work in primary and secondary care facilities. Most of the expatriate 
doctors in primary and district hospitals are non specialists with a diverse medical 
experience prior to practicing in Botswana. When these medical officers move to 
independent practice in primary and district hospitals, guidance is needed to assist in their 
work. Additionally, the variety of educational background of junior doctors in Botswana 
means that there is likely to be a wide range of practice standards. To mitigate the 
potential for divergence from established recommendations, local protocols are needed. A 
national protocol on the use of oxytocin during CS would offer guidance and perhaps 
curb maternal mortality that may result from inappropriate use of oxytocin in primary and 
district hospitals. However, before such a protocol is drawn up, the situation needs to be 
assessed. 
The standard of practice with regard to oxytocin in public health facilities has not been 
reported in Botswana. No protocols are in place to govern the way oxytocin is used 
during CS in the local setting. 
AIMS AND OBJECTIVES 
The main objective of this study is to establish the current standard of practice with 
regards to the use of oxytocin during CS. Furthermore, the study aims to identify areas of 
concern that may possibly be addressed by issuing locally produced practice guidelines 
and targeted continuing medical education programmes. This aim will be carried out 
through the following objectives: 
1. To establish and document the doses of oxytocin used at caesarean section at PMH. 
2. To establish and document the current routes of administration of oxytocin during 
caesarean sections at PMH. 
3. To establish and document the average estimated blood loss (EBL) during caesarean 
section at PMH where oxytocin was prescribed. 
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4. To establish and document the indications for caesarean section where oxytocin was 
prescribed at PMH. 
5. To establish and document the average age of the patients who have caesarean delivery 
and were prescribed oxytocin at PMH. 
6. To compare the rates of emergency versus elective caesarean sections where oxytocin 
was used. 
7. To compare the types of anaesthesia used during caesarean section when oxytocin was 
used. 
8. To compare current practice of oxytocin use in obstetrics at PMH with international 
best practice. 
METHODS 
Study design 
A clinical audit of current clinical practice involving routinely maintained medical 
records of patients who had caesarean section at Princess Marina Hospital, Botswana. 
Setting 
Princess Marina Hospital (PMH) is one of three major referral public hospitals in 
Botswana. It is located in the capital city of Gaborone and serves the greater Gaborone 
population as well as receiving referrals from other primary and secondary healthcare 
facilities in the southern part of the country, a catchment population of about a million 
people. In Botswana, the various clinicians directly involved with the use of oxytocin 
during caesarean section include medical officers, anaesthetic nurses, obstetrics & 
gynaecology specialists and specialist anaesthetists. Princess Marina serves as one of the 
training sites for internship by new medical graduates. The medical workforce of PMH is 
regularly reshuffled as doctors and nurses are transferred to various primary and 
secondary health care facilities in Botswana where they work with less specialist 
supervision. PMH was thus chosen as a setting for the present study as it has a high 
volume of cases and is a starting point for junior doctors returning from MBBS abroad 
Stellenbosch University  https://scholar.sun.ac.za
 12 
doing their housemanship en route to serve in various primary and district hospitals in 
Botswana. 
Princess Marina Hospital provides essential obstetric service for the population of over 
191 000 Gaborone residents and additionally receives referrals from primary and 
secondary health facilities in the southern part of Botswana. A dedicated obstetric and 
gynaecology theatre is operational on a 24 hour basis catering for emergency and elective 
operations. Medical officers (non specialists) in the department of obstetrics and 
gynaecology work on a rotational arrangement to attend to caesarean sections occurring 
at the hospital. Anaesthesia is similarly offered by the anaesthetic department medical 
officers, anaesthetic nurses and specialists. 
Decisions to perform emergency caesarean sections are made by the on-call medical 
officer. Decisions about elective caesarean sections are mostly effected by the 
obstetricians seeing patients referred from the catchment area primary care facilities, 
through the outpatient obstetric clinics. 
All post-caesarean section mothers are admitted to one post-natal ward with an average 
length of hospital stay of three to five days. Medical records of post CS patients including 
the anaesthetic record are kept in the ward until the patient is discharged.  
Selection / sampling of patients 
The study was conducted between 1st March 2011 and 31st May 2011. Data was 
transcribed from patients’ medical records of all women admitted to the post-natal ward 
following a CS done at PMH where oxytocin was used during and after the operation. 
Data Collection 
The principal researcher personally reviewed patients’ medical notes of all post-caesarean 
section patients admitted to the ward. These were identified from the admission register 
kept in the ward. The identified patient’s records were cross checked with the theatre 
record. The medication chart, operative notes and anaesthetic record where reviewed. 
Only patients who had been prescribed oxytocin were included. 
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A structured data collection form was developed to gather information on age; dose of 
oxytocin; route of administration; whether further doses of uterotonics were used; 
indication for CS; whether CS was elective or emergency; type of anaesthesia; estimated 
blood loss (EBL); and who prescribed the oxytocin. The information was transcribed into 
the data collection form and later into an electronic database (MS EXCEL). 
Where there was more than one indication for CS recorded on the patient’s notes, all 
were noted as separate indications in the results. Dystocia was taken to include 
cephalopelvic disproportion (CPD), delayed 1
st
 and 2
nd
 stage of labour and failed vacuum 
extraction.  
Data analysis 
Descriptive statistics were used for the analysis of the pooled data. Data was analysed 
descriptively as frequencies, means and percentages. 
Ethical consideration 
Ethical approval was obtained from the Health Research Ethics Committee at the 
University of Stellenbosch and the Research Ethics committees of the Botswana Ministry 
of Health and the Princess Marina Hospital. A waiver of patient consent was obtained 
since the study only required examination of routinely maintained medical records. 
RESULTS 
A total of 139 mothers who had a CS were included in the study with a mean maternal 
age of 28.9 years [range 16-43 years]. Out of the 139 CS operations included, 24 (17.3%) 
were elective and 115 (82.7%) were emergency. Table 1 shows that general anaesthesia 
(GA) was the most popular type of anaesthesia used during the study, accounting for 64% 
compared to 36% where spinal anaesthesia was used. In emergency CS, general 
anaesthesia was used in 81/115 (70.4%) of mothers as opposed to 8/24 (33.3%) of 
elective CS. Use of epidural anaesthesia was not reported. 
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Table1: Type of anaesthesia in emergency and elective caesarean section 
Anaesthesia Elective n [%]  Emergency 
n[%] 
Total 
n[%] 
Spinal 16  [11.5] 34 [24.5] 50 [36] 
General 
anaesthesia 
8     [5.6] 81  [58.3] 89 [64] 
Total 24 115 139 [100] 
 
The top three indications for CS were fetal distress 36(24.5%), dystocia 32(21.8%) and a 
previous CS 25(17%) as shown in Table 2 and Figure 1. One CS was performed for poor 
maternal effort, a reason not usually recognized as a standard obstetric indication for CS. 
Table 2: Indications for caesarean section (N=139) 
Indication Frequency Percentage 
Fetal Distress 36 24.5 
Dystocia 32 21.8 
Previous CS/Previous 
myectomy 
25 17 
Antepartum haemorrhage 13 8.8 
Transverse Lie/Malposition 
including breech 
12 8.2 
Failed Induction of labour/ 
Post dates 
10 6.8 
Eclampsia/severe Pre- 6 3.4 
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Eclampsia 
Other(multiple 
fibroids/twins/poor 
maternal effort) 
4 2.7 
Cord Prolapse 3 2 
Bad Obstetric History 2 1.4 
Medical condition 2 1.4 
Ruptured Uterus 1 0.7 
Intra Uterine Growth 
Restriction 
1 0.7 
Total *147 100 
 
*where multiple indications were recorded, all were noted as separate indications. 
Figure 1: Indications for caesarean section 
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The different indications for CS were represented to different extents depending on 
whether the CS was done as an emergency or elective operation. This is shown in Table 3 
and Table 4. 
Table 3: Indications for Emergency Caesarean Section 
Indication Frequency Percentage 
Fetal Distress 35 28.2 
Dystocia 29 23.4 
Previous Caesarean section in labour 14 11.3 
Antepartum Haemorrhage 13 10.5 
Malposition 12 9.7 
Eclampsia 6 4.8 
Cord prolapse 3 2.4 
Post dates 3 2.4 
Failed Induction of labour 2 1.6 
Medical condition 2 1.6 
Ruptured Uterus 1 0.8 
Intra Uterine Growth Restriction 1 0.8 
Bad Obstetric History 1 0.8 
Twins 1 0.8 
Poor Maternal effort 1 0.8 
Total 124 100 
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   Table 4: Indications for Elective Caesarean Section 
 
 
 
 
 
 
 
Prescribing practices differed widely with medical officers and anaesthetic nurses 
accounted for 100% of patients where the 10 iu intravenous bolus was used despite 
recommendations against this practice. Anaesthetic nurses accounted for the three 
patients where an intravenous bolus of 20 iu bolus was used.   
Different doses and routes of administration for oxytocin were observed as shown in 
Figure 2. The most common dose was 20 iu intravenous infusion (31.7%). Other 
regimens were: 5 iu intravenous bolus (29.5%); 10 iu intravenous infusion (20.1 %); 10 
iu intravenous bolus (12.9); 15 iu intravenous bolus (1.4%); 15 iu intravenous infusion 
(0.7%); 20 iu intravenous bolus (0.7%); 30 iu intravenous infusion (0.7%) and 40 iu 
intravenous infusion (0.7%). 
 
 
 
 
 
 
Indication Frequency Percentage 
Previous CS 12 50 
Dystocia 6 25 
Post dates 5 20.8 
Bad obstetric history 1 4.2 
Total 24 100 
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Figure 2: Different doses and routes of administration of oxytocin 
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Further doses of uterotonics were utilized in 57(41%) mothers. The regimens used 
included 10 iu oxytocin intravenous infusion; 15 iu oxytocin intravenous infusion; 20 iu 
oxytocin intravenous infusion and varying doses of syntometrine given by intramuscular 
injection. 
Estimated blood loss (EBL) ranged from 50-2000 ml. Table 5 shows the mean EBL and 
the doses of oxytocin prescribed when the EBL was estimated. This is graphically 
represented in Figure 3 which also shows the frequency of the different doses used. There 
was no direct relation observed between the EBL and the dose of oxytocin used. A 
clustering of patients with EBL below 500 ml was observed around the 5 iu intravenous 
bolus and the 20 iu infusion as shown in Table 6 for the 23 elective CS where EBL was 
documented. 
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Figure 3: Estimated blood loss (EBL) and oxytocin doses 
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Table 5: Dose of oxytocin used and estimated blood loss. 
Dose Average Blood 
Loss (ml) 
Blood loss 
range 
5 iu IV bolus 382 100 − 1500 
10 iu IV bolus 346 0 − 900 
10 iu IV infusion 320 100 − 900 
15 iu IV bolus 350 350 
15 iu IV infusion 100 100 − 200 
20 iu IV bolus 750 300 − 1200 
20 iu IV Infusion 493 100 − 2000 
30 iu IV infusion 500 500 − 1200 
40 iu IV infusion 500 500 
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Table 6: Blood loss vs oxytocin doses in elective patients 
Inf.: infusion 
 
DISCUSSION 
In the present study, it is evident that only 30% of users were adhering to the 
recommended practice of 5 iu intravenous oxytocin at CS as recommended by the RCOG 
and NICE guidelines. A total of 31.7% of participants in the study used an infusion of 20 
iu in one litre of a crystalloid solution. However, the infusion rate was not recorded as 
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given over two hours. This shows that the WHO guideline was only partially followed in 
the study.  
Very high doses were occasionally used during the study period. The high doses (20 iu 
bolus, 30 iu infusion, 40 iu infusion) were used mostly when EBL was more than or equal 
to 500ml although this observation was not consistent. By definition this degree of blood 
loss is considered to be post partum haemorrhage and infusions of this magnitude is 
expected in the management of such. However, in the setting of a CS, 500ml blood loss 
would be expected. So a dose relationship between blood loss and oxytocin might be 
expected, but this was not the case in this study. This may be partly due to the mixed 
population of elective and non-elective CS. The distribution of oxytocin doses in relation 
to EBL was only analysed among elective patients. [Table 6]. Blood loss is clustered at 
the lower ranges below 500ml in 21 patients out of the total 23 elective operations where 
it was documented but the oxytocin doses given ranged from 5 to 20 iu with majority of 
mothers receiving either a 5iu bolus or a 20 iu infusion. A 20 iu intravenous bolus of 
oxytocin is not recommended by any of the guidelines and is likely to be associated with 
adverse effects that could result in significant morbidity and mortality peri-
operatively.
6,7,8,10
 Estimation of blood loss at caesarean section has been shown elsewhere 
to vary widely according to a clinician’s perception.21 This is demonstrated by the wide 
range of EBL
 
demonstrated in this study.  
The proportion of emergency to elective CS was high. This is likely due to the fact that 
high risk pregnancies are referred as emergencies to PHM as a tertiary centre. Note the 
high rates of dystocia as an indication for emergency CS, which accounted for 29(20.9%) 
compared to only six (4.3%) done electively. This revelation is surprising considering the 
fact that over 90% of pregnant women in Botswana have had antenatal follow up and 
97% deliver in a health facility.
5
 This may mean that dystocia is not adequately predicted 
clinically in the antenatal period prior to delivery. Dystocia could be predicted and 
confirmed through clinical pelvimetry, a skill evidently in danger of being lost as a result 
of lack of training.
36
 
However, there is also the issue of definition of CPD as it is generally accepted in 
obstetrics that CPD cannot be excluded unless oxytocin is used.
36
 This implies that CPD 
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can only be diagnosed in labour when oxytocin has been used. In our study it was not 
clear as to whether any of the CPD cases received oxytocin in labour prior to the CS. 
However, all the CPD patients where diagnosed in labour. 
Overall, dystocia accounted for 21.8 % of indications for CS placing it among the top 
three indications for CS. This finding concurs with reports from Ghana where CPD was 
the second commonest indication for CS.
37 
In general terms, this is not too dissimilar to 
reports that CPD accounts for about 21-53% of all CS births in the developing world.
37
 
Fetal distress (FD) was noted as the commonest indication overall for CS and emergency 
CS where oxytocin was used, contributing 25% and 28.2% respectively. Although this 
study looked at a subset of pregnant women who were prescribed oxytocin during CS and 
not all CS, the percentages regarding fetal distress appear high. International studies 
suggest that rates for fetal distress as an indication for CS were as low as 6-17% in Ghana 
and as high as 46% in the UK for repeated emergency CS.
37,38 
The significant contribution of fetal distress as an indication for CS in our study begs the 
question of whether this entity is accurately diagnosed. In our setting, fetal distress is 
diagnosed on observation of fetal heart rate on cardiotocograph (CTG). Despite the high 
sensitivity of CTG in detecting fetal distress, it has the disadvantage of having a high rate 
of false positives as well as inter-and intra-observer variation.
39 
Confirmation of fetal 
distress (FD) through fetal scalp blood pH is not done in our setting. Perhaps this lack of 
laboratory confirmation of FD inadvertently leads to a lower threshold for diagnosing 
FD. Although fetal scalp blood sampling is a reassuring test to confirm FD, it is invasive 
and evidence for its use as gold standard is weak.
40 
The varied practices with regard to dosing and administration of oxytocin during CS 
revealed in this study, reflects an educational need. It is likely that such a wide variation 
will contribute to morbidity and mortality and perhaps establishment of protocols would 
rectify the problem. The groups that strayed from recommended practice most were non 
specialist doctors (medical officers) and anaesthetic nurses. This suggests that there may 
be a significant gap in knowledge amongst these groups and the obstetricians. However, 
during the study this group was also represented in larger numbers than the obstetricians. 
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This greater representation of medical officers was influenced by the fact that CS is 
delegated to medical officers in the local setting and obstetricians mostly get involved 
when their assistance is needed for complicated CS. 
General anaesthesia was the most popular type of anaesthesia used, especially in 
emergency CS. The rates of general anaesthesia appear higher than in other African 
countries such as Nigeria, which reported a rate of 47.6%.
41
 The high uptake of general 
anaesthesia as opposed to regional anaesthesia in the present study potentially increases 
anaesthesia related causes of maternal morbidity and mortality. This is supported by the 
fact that most of the direct anaesthetic deaths reported to the Confidential Inquiries into 
Maternal Deaths involved general anaesthetic.
42 
The results of the audit were presented at a joint meeting of the department of obstetrics 
and gynaecology and the department of anaesthesia. There was a general consensus about 
the need to develop a local protocol on the use of oxytocin during CS. 
Strengths and weaknesses of the study 
The unique setting of PMH that provides local district hospital type services and regional 
referral hospital services with a high volume of patients, presents a peculiar advantage in 
conducting this study. A variety of users were represented in the study with the majority 
being non- specialists, a situation closer in reality to the staff compliment of primary and 
district hospitals. 
The study did not identify specific individuals (but rather groups) who prescribed specific 
doses and thus potentially harmful practice could not be linked to specific individuals. 
However, this is useful in not creating a climate of blame, a clear objective of clinical 
audit. 
The study could not clearly distinguish whether oxytocin was primarily given as 
prophylaxis or treatment since this was not stated in the patients’ records from which data 
was transcribed. This highlights the fact that patient notes were not being adequately 
recorded. The question would have been addressed better in a prospective study when 
prescribers indication for use of oxytocin could have been defined. 
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Implications and recommendations 
A focus on improvement of current clinical practice with regard to the use of oxytocin 
during CS could follow the following recommendations: 
1. Develop a national protocol for prophylactic use of oxytocin at caesarean section. 
Such a protocol should take into account currently available data presented in 
scientific literature and reviewed here. The protocol should afford a choice to use a 
slow bolus of 5 iu or less OR an infusion of 20 iu in one litre of crystalloid given over 
two hours. 
2. Junior doctors, anaesthetic nurses and non-specialist doctors transferred to primary 
and district hospitals should be targeted for Continuing Medical Education (CME) 
activities that include training on appropriate use of oxytocin at CS. This should also 
be addressed in the initial training of these clinicians and that of family physicians as 
they rotate through the departments of obstetrics and anaesthetics. 
3. The results of the audit to be discussed at departmental meeting of obstetrics and 
anaesthesia and at a general clinical meeting (grand rounds) at PMH. 
4. Review (re-audit) to complete the cycle through similar processes after 
implementation of recommendations. These could be done as early as three months 
after implementation of the recommendation.  
CONCLUSIONS 
The use of oxytocin during CS in the local setting does not generally follow 
recommended practice and current literature. This has potentially harmful consequences 
such as increased maternal morbidity and mortality. Education and guidance by national 
practice guidelines and protocols could help alleviate the problem. This audit could be 
used as a baseline for future assessment of clinical practice at PMH and as a stimulus to 
similar clinical audits in other centres.  
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